We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NHTC:NASDAQNatural Health Trends Corp. - Commn Stock Analysis

Data as of 2026-05-20 - not real-time

$2.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Natural Health Trends Corp. is trading just above its short‑term support level of $2.76, with the 20‑day SMA marginally higher than the market price, while the 200‑day SMA remains well above, underscoring a long‑term downtrend. The RSI sits in the low‑40s, suggesting limited upside momentum, and the MACD histogram is negative, confirming bearish pressure. Volatility is elevated at over 43% for the past 30 days, and the beta of roughly 0.58 indicates the stock moves less than the market but still reflects heightened risk in a volatile environment. The Fear & Greed Index is in "Extreme Greed" territory, hinting that market sentiment may be overly optimistic despite the fundamentals. Recent earnings disclosed a 14% YoY revenue decline to $9.2 M, with operating losses persisting and cash flow negative, while management noted trade‑war pressures and modest improvements in gross margin. Stable order flow in Hong Kong and China over the last four quarters and a $300 K restructuring benefit provide a slight operational cushion, yet the lack of EPS guidance and a nominal $0.10 dividend raise questions about sustainability. Overall, the stock appears discounted relative to its book value but is weighed down by weak earnings, high volatility, and macro‑economic headwinds.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Price near technical support with bearish MACD
  • Negative earnings and cash flow
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential stabilization from restructuring and AI‑app rollout
  • Continued exposure to trade‑war and consumer spending risks
  • Valuation discount to book value offering limited upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamental turnaround required to reverse revenue decline
  • International market diversification mitigates single‑region risk
  • Low beta suggests less market correlation if profitability improves

Key Metrics & Analysis

Financial Health

Revenue Growth-14.30%
Profit Margin-3.03%
ROE-4.89%
ROA-2.84%
Debt/Equity18.36
P/B Ratio1.4
Op. Cash Flow$-7278000
Free Cash Flow$-6929625

Technical Analysis

TrendNeutral
RSI41.1
Support$2.76
Resistance$3.28
MA 20$2.99
MA 50$2.92
MA 200$3.60
MACDBearish
VolumeIncreasing
Fear & Greed Index89.71

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.58
Volatility43.29%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.